Mfsd2ab mutants do not have altered BBB permeability.
(A) Representative maximum intensity projection images of the brain of wild-type and mfsd2ab mutants expressing the fluorescently labeled 80 kDa transgenic serum protein DBP-EGFP (green) at 5 dpf. Mfsd2ab mutants have a similarly low level of DBP-EGFP in the midbrain and hindbrain parenchyma compared to wild-type siblings. The scale bar represents 50 µm. (B) Quantification of normalized parenchymal tracer intensity (NHS and DBP-EGFP) in the midbrain and hindbrain of wild-type (black) and mfsd2ab mutants (green). Mfsd2ab mutants display no significant barrier permeability defects, both for the injected NHS and the endogenous transgene DBP-EGFP (A). Each individual fish measured is displayed as a single point. The mean and the standard error are drawn in black.
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Elife
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if
additional information is required.
Oops. Something went wrong. Please try again later.